Develops magnetic resonance-guided focused ultrasound (MRgFUS) systems for incision-free ablation of diseased tissue.
Profound Medical Corp. is a pioneering medical device company focused on advancing magnetic resonance guided ablation procedures for the treatment of various conditions. Operating across Canada, Germany, the United States, and Finland, the company specializes in innovative therapies for prostate disease, uterine fibroids, and palliative pain management. At the forefront of its product lineup is the TULSA-PRO system, which integrates seamlessly with magnetic resonance imaging scanners in hospital and treatment settings, offering precise and effective treatment options.
In addition to its flagship TULSA-PRO system, Profound Medical Corp. offers the Sonalleve platform. This therapeutic solution is designed for the non-invasive treatment of uterine fibroids and provides palliative pain relief for patients with metastases in bone. With a commitment to advancing medical technology, the company continues to expand its capabilities in enhancing treatment outcomes and improving quality of life for patients.
Headquartered in Mississauga, Canada, Profound Medical Corp. remains dedicated to innovation in medical devices and therapies. By leveraging magnetic resonance guidance, the company aims to redefine standards in medical ablation procedures, ofering advanced solutions that address significant medical challenges across global markets.